The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...

Intel Corporation, Qualcomm Incorporated, Advanced Micro Devices Inc. Read 's Market Analysis on Investing.com ...

US stocks slipped on Tuesday (May 20) as the tech-driven rally lost momentum. The S&P 500 fell 0.39% to close at 5,940.46, ...

Advanced Micro Devices, Inc. continues to show strong growth, especially in AI and data center segments. Learn more about AMD ...

US stock futures slide after Moodys downgraded the countrys credit rating from “Aaa” to “Aa1,” raising alarm over Americas ...

Advanced Micro Devices shares fell Thursday after gaining ground for six consecutive days amid optimism about recently announced AI deals and share buyback plans. Monitor these crucial support and ...

Financial Highlights for the Fiscal Second Quarter Ended March 31, 2025 ...

Advanced Micro Devices stock (NASDAQ:AMD) increased by more than 4% during Tuesday's trading session and has risen by nearly ...

As the Trump administration’s trade war clouds the economic outlook, software stocks have emerged as a favorite place for investors looking for a respite.

Artificial intelligence (AI) is completely reshaping how businesses operate. It promises to speed up productivity, product ...

Advanced Micro Devices has an undervalued stock and strong fundamentals, driven by growth catalysts and strategic moves. Click here to read why AMD is a Buy.